Intensive chemotherapy with idarubicin, cytarabine and G-CSF in elderly patients with acute myelogenous leukemia (AML)

被引：0
|
作者：
Chaibi, P [1 ]
Dombret, H [1 ]
Rousselot, P [1 ]
Gardin, C [1 ]
Glaisner, S [1 ]
Castaigne, S [1 ]
Degos, L [1 ]
机构：
[1] HOP ST LOUIS,SERV CLIN MALAD SANG,PARIS,FRANCE
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 1996年 / 93卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：822 / 822
页数：1
相关论文
共 50 条
  • [1] Intensive chemotherapy with idarubicin, cytosine arabinoside, and G-CSF in patients with secondary and therapy-related acute myelogenous leukemia.
    Chaibi, P
    Gardin, C
    deRevel, T
    Rousselot, P
    Turlure, P
    KulekciSauvage, C
    Veil, A
    Sutton, L
    Miclea, JM
    Nedellec, G
    Dombret, H
    BLOOD, 1995, 86 (10) : 2061 - 2061
  • [2] G-CSF after intensive consolidation chemotherapy in acute myeloid leukemia (AML).
    Harousseau, JL
    Witz, F
    Desablens, B
    Leprise, PY
    Francois, S
    Delain, M
    Abgrall, JF
    Solary, E
    BLOOD, 1997, 90 (10) : 2249 - 2249
  • [3] Intensive chemotherapy with idarubicin, cytarabine, etoposide, and G-CSF priming in patients with advanced myelodysplastic syndrome and high-risk acute myeloid leukemia
    Hofmann, WK
    Heil, G
    Zander, C
    Wiebe, S
    Ottmann, OG
    Bergmann, L
    Hoeffken, K
    Fischer, JT
    Knuth, A
    Kolbe, K
    Schmoll, HJ
    Langer, W
    Westerhausen, M
    Koelbel, CB
    Hoelzer, D
    Ganser, A
    ANNALS OF HEMATOLOGY, 2004, 83 (08) : 498 - 503
  • [4] Intensive chemotherapy with idarubicin, cytarabine, etoposide, and G-CSF priming in patients with advanced myelodysplastic syndrome and high-risk acute myeloid leukemia
    W. K. Hofmann
    G. Heil
    C. Zander
    S. Wiebe
    O. G. Ottmann
    L. Bergmann
    K. Hoeffken
    J. T. Fischer
    A. Knuth
    K. Kolbe
    H. J. Schmoll
    W. Langer
    M. Westerhausen
    C. B. Koelbel
    D. Hoelzer
    A. Ganser
    Annals of Hematology, 2004, 83 : 498 - 503
  • [5] G-CSF after intensive consolidation chemotherapy (ICC) in acute myeloid leukemia (AML)
    Harousseau, JL
    Witz, F
    Lioure, B
    Leprise, PY
    Solary, E
    Abgrall, JF
    Cassasus, P
    Audhuy, B
    Travade, P
    Cahn, JY
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (01) : 86 - 86
  • [6] Intensive chemotherapy with idarubicin, cytosine arabinoside, and granulocyte colony-stimulating factor (G-CSF) in patients with secondary and therapy-related acute myelogenous leukemia
    Gardin, C
    Chaibi, P
    deRevel, T
    Rousselot, P
    Turlure, P
    Miclea, JM
    Nedellec, G
    Dombret, H
    LEUKEMIA, 1997, 11 (01) : 16 - 21
  • [7] Intensive chemotherapy with idarubicin, cytosine arabinoside, and granulocyte colony-stimulating factor (G-CSF) in patients with secondary and therapy-related acute myelogenous leukemia
    C Gardin
    P Chaibi
    T de Revel
    P Rousselot
    P Turlure
    JM Micléa
    G Nédellec
    H Dombret
    Leukemia, 1997, 11 : 16 - 21
  • [8] G-CSF priming in acute myelogenous leukemia
    Murashige, N
    Kami, M
    Takaue, Y
    NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (21): : 2071 - 2072
  • [9] Treatment of resistant or relapsed AML and MDS with the combination of G-CSF, cyclosporin, idarubicin and cytarabine
    Smeets, M
    Raymakers, R
    Vierwinden, G
    Linssen, P
    Muus, P
    De Witte, T
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (01) : 222 - 222
  • [10] Economic evaluation of G-CSF use in the therapy of adult acute myelogenous leukemia (AML).
    Maslak, P
    Weiss, M
    Berman, E
    Tyson, D
    Sheinberg, D
    BLOOD, 1996, 88 (10) : 827 - 827
12345